Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2012

Open Access 01-12-2012 | Original investigation

Erythropoietin, ferritin, haptoglobin, hemoglobin and transferrin receptor in metabolic syndrome: a case control study

Authors: Päivi Hämäläinen, Juha Saltevo, Hannu Kautiainen, Pekka Mäntyselkä, Mauno Vanhala

Published in: Cardiovascular Diabetology | Issue 1/2012

Login to get access

Abstract

Background

Increased ferritin concentrations are associated with metabolic syndrome (MetS). The association between ferritin as well as hemoglobin level and individual MetS components is unclear. Erythropoietin levels in subjects with MetS have not been determined previously. The aim of this study was to compare serum erythropoietin, ferritin, haptoglobin, hemoglobin, and transferrin receptor (sTFR) levels between subjects with and without MetS and subjects with individual MetS components.

Methods

A population based cross-sectional study of 766 Caucasian, middle-aged subjects (341 men and 425 women) from five age groups born in Pieksämäki, Finland who were invited to a health check-up in 2004 with no exclusion criteria. Laboratory analyzes of blood samples collected in 2004 were done during year 2010. MetS was defined by National Cholesterol Education Program criteria.

Results

159 (53%) men and 170 (40%) women of study population met MetS criteria. Hemoglobin and ferritin levels as well as erythropoietin and haptoglobin levels were higher in subjects with MetS (p < 0.001, p = 0.018). sTFR level did not differ significantly between subjects with or without MetS. Hemoglobin level was significantly higher in subjects with any of the MetS components (p < 0.001, p = 0.002). Ferritin level was significantly higher in subjects with abdominal obesity or high TG or elevated glucose or low high density cholesterol component (p < 0.001, p = 0.002, p = 0.02). Erythropoietin level was significantly higher in subjects with abdominal obesity component (p = 0.015) but did not differ significantly between subjects with or without other MetS components. Haptoglobin level was significantly higher in subjects with blood pressure or elevated glucose component o MetS (p = 0.028, p = 0.025).

Conclusion

Subjects with MetS have elevated hemoglobin, ferritin, erythropoietin and haptoglobin concentrations. Higher hemoglobin levels are related to all components of MetS. Higher ferritin levels associate with TG, abdominal obesity, elevated glucose or low high density cholesterol. Haptoglobin levels associate with blood pressure or elevated glucose. However, erythropoietin levels are related only with abdominal obesity. Higher serum erythropoietin concentrations may suggest underlying adipose tissue hypoxemia in MetS.
Appendix
Available only for authorised users
Literature
1.
go back to reference Despres JP, Lemieux I: Abdominal obesity and metabolic syndrome. Nature. 2006, 444 (7121): 881-887. 10.1038/nature05488.CrossRefPubMed Despres JP, Lemieux I: Abdominal obesity and metabolic syndrome. Nature. 2006, 444 (7121): 881-887. 10.1038/nature05488.CrossRefPubMed
2.
go back to reference Hermans MP, Ahn SA, Rousseau MF: log(TG)/HDL-C is related to both residual cardiometabolic risk and beta-cell function loss in type 2 diabetes males. Cardiovasc Diabetol. 2010, 9: 88-10.1186/1475-2840-9-88.PubMedCentralCrossRefPubMed Hermans MP, Ahn SA, Rousseau MF: log(TG)/HDL-C is related to both residual cardiometabolic risk and beta-cell function loss in type 2 diabetes males. Cardiovasc Diabetol. 2010, 9: 88-10.1186/1475-2840-9-88.PubMedCentralCrossRefPubMed
3.
go back to reference Kang HT, Linton JA, Shim JY: Serum ferritin level is associated with the prevalence of metabolic syndrome in Korean adults: the 2007–2008 Korean National Health and Nutrition Examination Survey. Clin Chim Acta. 2012, 413 (5–6): 636-641.CrossRefPubMed Kang HT, Linton JA, Shim JY: Serum ferritin level is associated with the prevalence of metabolic syndrome in Korean adults: the 2007–2008 Korean National Health and Nutrition Examination Survey. Clin Chim Acta. 2012, 413 (5–6): 636-641.CrossRefPubMed
4.
go back to reference Lecube A, Hernandez C, Pelegri D, Simo R: Factors accounting for high ferritin levels in obesity. Int J Obes (Lond). 2008, 32 (11): 1665-1669. 10.1038/ijo.2008.154.CrossRef Lecube A, Hernandez C, Pelegri D, Simo R: Factors accounting for high ferritin levels in obesity. Int J Obes (Lond). 2008, 32 (11): 1665-1669. 10.1038/ijo.2008.154.CrossRef
5.
go back to reference Sun L, Franco OH, Hu FB, Cai L, Yu Z, Li H, Ye X, Qi Q, Wang J, Pan A, Liu Y, Lin X: Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle-aged and elderly chinese. J Clin Endocrinol Metab. 2008, 93 (12): 4690-4696. 10.1210/jc.2008-1159.CrossRefPubMed Sun L, Franco OH, Hu FB, Cai L, Yu Z, Li H, Ye X, Qi Q, Wang J, Pan A, Liu Y, Lin X: Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle-aged and elderly chinese. J Clin Endocrinol Metab. 2008, 93 (12): 4690-4696. 10.1210/jc.2008-1159.CrossRefPubMed
6.
go back to reference Bozzini C, Girelli D, Olivieri O, Martinelli N, Bassi A, De Matteis G, Tenuti I, Lotto V, Friso S, Pizzolo F, Corrocher R: Prevalence of body iron excess in the metabolic syndrome. Diabetes Care. 2005, 28 (8): 2061-2063. 10.2337/diacare.28.8.2061.CrossRefPubMed Bozzini C, Girelli D, Olivieri O, Martinelli N, Bassi A, De Matteis G, Tenuti I, Lotto V, Friso S, Pizzolo F, Corrocher R: Prevalence of body iron excess in the metabolic syndrome. Diabetes Care. 2005, 28 (8): 2061-2063. 10.2337/diacare.28.8.2061.CrossRefPubMed
7.
go back to reference Jelkmann W: Erythropoietin: structure, control of production, and function. Physiol Rev. 1992, 72 (2): 449-489.PubMed Jelkmann W: Erythropoietin: structure, control of production, and function. Physiol Rev. 1992, 72 (2): 449-489.PubMed
8.
go back to reference Pasarica M, Sereda OR, Redman LM, Albarado DC, Hymel DT, Roan LE, Rood JC, Burk DH, Smith SR: Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes. 2009, 58 (3): 718-725.PubMedCentralCrossRefPubMed Pasarica M, Sereda OR, Redman LM, Albarado DC, Hymel DT, Roan LE, Rood JC, Burk DH, Smith SR: Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes. 2009, 58 (3): 718-725.PubMedCentralCrossRefPubMed
9.
go back to reference Regazzetti C, Peraldi P, Gremeaux T, Najem-Lendom R, Ben-Sahra I, Cormont M, Bost F, Le Marchand-Brustel Y, Tanti JF, Giorgetti-Peraldi S: Hypoxia decreases insulin signaling pathways in adipocytes. Diabetes. 2009, 58 (1): 95-103. 10.2337/db08-0457.PubMedCentralCrossRefPubMed Regazzetti C, Peraldi P, Gremeaux T, Najem-Lendom R, Ben-Sahra I, Cormont M, Bost F, Le Marchand-Brustel Y, Tanti JF, Giorgetti-Peraldi S: Hypoxia decreases insulin signaling pathways in adipocytes. Diabetes. 2009, 58 (1): 95-103. 10.2337/db08-0457.PubMedCentralCrossRefPubMed
10.
go back to reference Wood IS, de Heredia FP, Wang B, Trayhurn P: Cellular hypoxia and adipose tissue dysfunction in obesity. Proc Nutr Soc. 2009, 68 (4): 370-377. 10.1017/S0029665109990206.CrossRefPubMed Wood IS, de Heredia FP, Wang B, Trayhurn P: Cellular hypoxia and adipose tissue dysfunction in obesity. Proc Nutr Soc. 2009, 68 (4): 370-377. 10.1017/S0029665109990206.CrossRefPubMed
11.
go back to reference Vanhala M, Saltevo J, Soininen P, Kautiainen H, Kangas AJ, Ala-Korpela M, Mantyselka P: Serum omega-6 polyunsaturated fatty acids and the metabolic syndrome: a longitudinal population-based cohort study. Am J Epidemiol. 2012, 176 (3): 253-260. 10.1093/aje/kwr504.CrossRefPubMed Vanhala M, Saltevo J, Soininen P, Kautiainen H, Kangas AJ, Ala-Korpela M, Mantyselka P: Serum omega-6 polyunsaturated fatty acids and the metabolic syndrome: a longitudinal population-based cohort study. Am J Epidemiol. 2012, 176 (3): 253-260. 10.1093/aje/kwr504.CrossRefPubMed
12.
go back to reference Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC: International Diabetes Federation Task Force on Epidemiology and Prevention, Hational Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society, International Association for the Study of Obesity: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009, 120 (16): 1640-1645. 10.1161/CIRCULATIONAHA.109.192644.CrossRefPubMed Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC: International Diabetes Federation Task Force on Epidemiology and Prevention, Hational Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society, International Association for the Study of Obesity: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009, 120 (16): 1640-1645. 10.1161/CIRCULATIONAHA.109.192644.CrossRefPubMed
13.
go back to reference Cancello R, Henegar C, Viguerie N, Taleb S, Poitou C, Rouault C, Coupaye M, Pelloux V, Hugol D, Bouillot JL, Bouloumie A, Barbatelli G, Cinti S, Svensson PA, Barsh GS, Zucker JD, Basdevant A, Langin D, Clement K: Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes. 2005, 54 (8): 2277-2286. 10.2337/diabetes.54.8.2277.CrossRefPubMed Cancello R, Henegar C, Viguerie N, Taleb S, Poitou C, Rouault C, Coupaye M, Pelloux V, Hugol D, Bouillot JL, Bouloumie A, Barbatelli G, Cinti S, Svensson PA, Barsh GS, Zucker JD, Basdevant A, Langin D, Clement K: Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes. 2005, 54 (8): 2277-2286. 10.2337/diabetes.54.8.2277.CrossRefPubMed
14.
go back to reference Lohsoonthorn V, Jiamjarasrungsi W, Williams MA: Association of hematological parameters with clustered components of metabolic syndrome among professional and office workers in Bangkok, Thailand. Diabetes Metab Syndr. 2007, 1 (3): 143-149. 10.1016/j.dsx.2007.05.002.PubMedCentralCrossRefPubMed Lohsoonthorn V, Jiamjarasrungsi W, Williams MA: Association of hematological parameters with clustered components of metabolic syndrome among professional and office workers in Bangkok, Thailand. Diabetes Metab Syndr. 2007, 1 (3): 143-149. 10.1016/j.dsx.2007.05.002.PubMedCentralCrossRefPubMed
15.
go back to reference Muraki I, Tanigawa T, Yamagishi K, Sakurai S, Ohira T, Imano H, Kiyama M, Kitamura A, Sato S, Shimamoto T, Konishi M, Iso H, CIRCS Investigators: Nocturnal intermittent hypoxia and metabolic syndrome; the effect of being overweight: the CIRCS study. J Atheroscler Thromb. 2010, 17 (4): 369-377. 10.5551/jat.3319.CrossRefPubMed Muraki I, Tanigawa T, Yamagishi K, Sakurai S, Ohira T, Imano H, Kiyama M, Kitamura A, Sato S, Shimamoto T, Konishi M, Iso H, CIRCS Investigators: Nocturnal intermittent hypoxia and metabolic syndrome; the effect of being overweight: the CIRCS study. J Atheroscler Thromb. 2010, 17 (4): 369-377. 10.5551/jat.3319.CrossRefPubMed
16.
go back to reference Cahan C, Decker MJ, Arnold JL, Goldwasser E, Strohl KP: Erythropoietin levels with treatment of obstructive sleep apnea. J Appl Physiol. 1995, 79 (4): 1278-1285.PubMed Cahan C, Decker MJ, Arnold JL, Goldwasser E, Strohl KP: Erythropoietin levels with treatment of obstructive sleep apnea. J Appl Physiol. 1995, 79 (4): 1278-1285.PubMed
17.
go back to reference Calvin AD, Somers VK, Steensma DP, Rio Perez JA, van der Walt C, Fitz-Gibbon JM, Scott CG, Olson LJ: Advanced heart failure and nocturnal hypoxaemia due to central sleep apnoea are associated with increased serum erythropoietin. Eur J Heart Fail. 2010, 12 (4): 354-359. 10.1093/eurjhf/hfq005.PubMedCentralCrossRefPubMed Calvin AD, Somers VK, Steensma DP, Rio Perez JA, van der Walt C, Fitz-Gibbon JM, Scott CG, Olson LJ: Advanced heart failure and nocturnal hypoxaemia due to central sleep apnoea are associated with increased serum erythropoietin. Eur J Heart Fail. 2010, 12 (4): 354-359. 10.1093/eurjhf/hfq005.PubMedCentralCrossRefPubMed
18.
go back to reference Jehn ML, Guallar E, Clark JM, Couper D, Duncan BB, Ballantyne CM, Hoogeveen RC, Harris ZL, Pankow JS: A prospective study of plasma ferritin level and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol. 2007, 165 (9): 1047-1054. 10.1093/aje/kwk093.CrossRefPubMed Jehn ML, Guallar E, Clark JM, Couper D, Duncan BB, Ballantyne CM, Hoogeveen RC, Harris ZL, Pankow JS: A prospective study of plasma ferritin level and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol. 2007, 165 (9): 1047-1054. 10.1093/aje/kwk093.CrossRefPubMed
19.
go back to reference Jiang R, Manson JE, Meigs JB, Ma J, Rifai N, Hu FB: Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA. 2004, 291 (6): 711-717. 10.1001/jama.291.6.711.CrossRefPubMed Jiang R, Manson JE, Meigs JB, Ma J, Rifai N, Hu FB: Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA. 2004, 291 (6): 711-717. 10.1001/jama.291.6.711.CrossRefPubMed
20.
go back to reference He M, Workalemahu T, Manson JE, Hu FB, Qi L: Genetic determinants for body iron store and type 2 diabetes risk in US men and women. PLoS One. 2012, 7 (7): e40919-10.1371/journal.pone.0040919.PubMedCentralCrossRefPubMed He M, Workalemahu T, Manson JE, Hu FB, Qi L: Genetic determinants for body iron store and type 2 diabetes risk in US men and women. PLoS One. 2012, 7 (7): e40919-10.1371/journal.pone.0040919.PubMedCentralCrossRefPubMed
21.
go back to reference Zuliani G, Volpato S, Galvani M, Ble A, Bandinelli S, Corsi AM, Lauretani F, Maggio M, Guralnik JM, Fellin R, Ferrucci L: Elevated C-reactive protein levels and metabolic syndrome in the elderly: the role of central obesity data from the InChianti study. Atherosclerosis. 2009, 203: 626-632. 10.1016/j.atherosclerosis.2008.07.038.PubMedCentralCrossRefPubMed Zuliani G, Volpato S, Galvani M, Ble A, Bandinelli S, Corsi AM, Lauretani F, Maggio M, Guralnik JM, Fellin R, Ferrucci L: Elevated C-reactive protein levels and metabolic syndrome in the elderly: the role of central obesity data from the InChianti study. Atherosclerosis. 2009, 203: 626-632. 10.1016/j.atherosclerosis.2008.07.038.PubMedCentralCrossRefPubMed
22.
go back to reference Lu B, Yang Y, Yang Z, Feng X, Wang X, Zhang Z, Hu R: Insulin resistance in Chinese patients with type 2 diabetes is associated with C-reactive protein independent of abdominal obesity. Cardiovasc Diabetol. 2010, 9: 92-10.1186/1475-2840-9-92.PubMedCentralCrossRefPubMed Lu B, Yang Y, Yang Z, Feng X, Wang X, Zhang Z, Hu R: Insulin resistance in Chinese patients with type 2 diabetes is associated with C-reactive protein independent of abdominal obesity. Cardiovasc Diabetol. 2010, 9: 92-10.1186/1475-2840-9-92.PubMedCentralCrossRefPubMed
23.
go back to reference Frohlich M, Imhof A, Berg G, Hutchinson WL, Pepys MB, Boeing H, Muche R, Brenner H, Koenig W: Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care. 2000, 23: 1835-1839. 10.2337/diacare.23.12.1835.CrossRefPubMed Frohlich M, Imhof A, Berg G, Hutchinson WL, Pepys MB, Boeing H, Muche R, Brenner H, Koenig W: Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care. 2000, 23: 1835-1839. 10.2337/diacare.23.12.1835.CrossRefPubMed
24.
go back to reference den Engelsen C, Koekkoek PS, Gorter KJ, van den Donk M, Salome PL, Rutten GE: High-sensitivity C-reactive protein to detect metabolic syndrome in a centrally obese population: a cross-sectional analysis. Cardiovasc Diabetol. 2012, 11: 25-10.1186/1475-2840-11-25.PubMedCentralCrossRefPubMed den Engelsen C, Koekkoek PS, Gorter KJ, van den Donk M, Salome PL, Rutten GE: High-sensitivity C-reactive protein to detect metabolic syndrome in a centrally obese population: a cross-sectional analysis. Cardiovasc Diabetol. 2012, 11: 25-10.1186/1475-2840-11-25.PubMedCentralCrossRefPubMed
25.
go back to reference Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, Beaumont C, Kahn A, Vaulont S: The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest. 2002, 110 (7): 1037-1044.PubMedCentralCrossRefPubMed Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, Beaumont C, Kahn A, Vaulont S: The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest. 2002, 110 (7): 1037-1044.PubMedCentralCrossRefPubMed
27.
go back to reference Bekri S, Gual P, Anty R, Luciani N, Dahman M, Ramesh B, Iannelli A, Staccini-Myx A, Casanova D, Ben Amor I, Saint-Paul MC, Huet PM, Sadoul JL, Gugenheim J, Srai SK, Tran A, Le Marchand-Brustel Y: Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology. 2006, 131 (3): 788-796. 10.1053/j.gastro.2006.07.007.CrossRefPubMed Bekri S, Gual P, Anty R, Luciani N, Dahman M, Ramesh B, Iannelli A, Staccini-Myx A, Casanova D, Ben Amor I, Saint-Paul MC, Huet PM, Sadoul JL, Gugenheim J, Srai SK, Tran A, Le Marchand-Brustel Y: Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology. 2006, 131 (3): 788-796. 10.1053/j.gastro.2006.07.007.CrossRefPubMed
28.
go back to reference Gabay C, Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999, 340 (6): 448-454. 10.1056/NEJM199902113400607.CrossRefPubMed Gabay C, Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999, 340 (6): 448-454. 10.1056/NEJM199902113400607.CrossRefPubMed
29.
go back to reference Quaye IK: Haptoglobin, inflammation and disease. Trans R Soc Trop Med Hyg. 2008, 102 (8): 735-742. 10.1016/j.trstmh.2008.04.010.CrossRefPubMed Quaye IK: Haptoglobin, inflammation and disease. Trans R Soc Trop Med Hyg. 2008, 102 (8): 735-742. 10.1016/j.trstmh.2008.04.010.CrossRefPubMed
30.
go back to reference Chiellini C, Santini F, Marsili A, Berti P, Bertacca A, Pelosini C, Scartabelli G, Pardini E, Lopez-Soriano J, Centoni R, Ciccarone AM, Benzi L, Vitti P, Del Prato S, Pinchera A, Maffei M: Serum haptoglobin: a novel marker of adiposity in humans. J Clin Endocrinol Metab. 2004, 89 (6): 2678-2683. 10.1210/jc.2003-031965.CrossRefPubMed Chiellini C, Santini F, Marsili A, Berti P, Bertacca A, Pelosini C, Scartabelli G, Pardini E, Lopez-Soriano J, Centoni R, Ciccarone AM, Benzi L, Vitti P, Del Prato S, Pinchera A, Maffei M: Serum haptoglobin: a novel marker of adiposity in humans. J Clin Endocrinol Metab. 2004, 89 (6): 2678-2683. 10.1210/jc.2003-031965.CrossRefPubMed
31.
go back to reference Skikne BS, Flowers CH, Cook JD: Serum transferrin receptor: a quantitative measure of tissue iron deficiency. Blood. 1990, 75 (9): 1870-1876.PubMed Skikne BS, Flowers CH, Cook JD: Serum transferrin receptor: a quantitative measure of tissue iron deficiency. Blood. 1990, 75 (9): 1870-1876.PubMed
32.
go back to reference Ahluwalia N, Skikne BS, Savin V, Chonko A: Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure. Am J Kidney Dis. 1997, 30 (4): 532-541. 10.1016/S0272-6386(97)90313-9.CrossRefPubMed Ahluwalia N, Skikne BS, Savin V, Chonko A: Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure. Am J Kidney Dis. 1997, 30 (4): 532-541. 10.1016/S0272-6386(97)90313-9.CrossRefPubMed
33.
go back to reference Tussing-Humphreys LM, Nemeth E, Fantuzzi G, Freels S, Guzman G, Holterman AX, Braunschweig C: Elevated systemic hepcidin and iron depletion in obese premenopausal females. Obesity (Silver Spring). 2010, 18 (7): 1449-1456. 10.1038/oby.2009.319.CrossRef Tussing-Humphreys LM, Nemeth E, Fantuzzi G, Freels S, Guzman G, Holterman AX, Braunschweig C: Elevated systemic hepcidin and iron depletion in obese premenopausal females. Obesity (Silver Spring). 2010, 18 (7): 1449-1456. 10.1038/oby.2009.319.CrossRef
Metadata
Title
Erythropoietin, ferritin, haptoglobin, hemoglobin and transferrin receptor in metabolic syndrome: a case control study
Authors
Päivi Hämäläinen
Juha Saltevo
Hannu Kautiainen
Pekka Mäntyselkä
Mauno Vanhala
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2012
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-11-116

Other articles of this Issue 1/2012

Cardiovascular Diabetology 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.